Lineage Cell Therapeutics, Inc. announced that on Effective July 8, 2022, Brian M. Culley, Lineage's Chief Executive Officer, will serve as Lineage's principal financial officer, and Alexandra Hernandez, Lineage's Sr. Director of Finance and Controller, will serve as Lineage's interim principal accounting officer. Ms. Hernandez joined Lineage as Sr. Director of Finance and Controller in September 2019. Prior to joining Lineage, Ms. Hernandez served as Director, Accounting and Assistant Controller of OncoSec Medical Incorporated from June 2017 to August 2019.

From April 2011 to May 2017, Ms. Hernandez served as Associate Director, Accounting of Mast Therapeutics, Inc. From 2007 to 2011, Ms. Hernandez consulted for Premier Alliance Group, Inc., a professional services provider, and from 2004 to 2007, Ms. Hernandez served as a Senior Accountant for 24 Hour Fitness USA, Inc. Ms. Hernandez is a certified public accountant with the State of California and received her B.S. degree in business administration from San Diego State University.